Indian researchers have developed a new AI-powered tool that uses deep learning to identify hidden cancer cells, outperforming traditional diagnostic methods in early-stage detection.
The tool, unveiled on August 14, 2026, analyzes tissue samples to pinpoint metastatic cells that are often missed by human pathologists, potentially improving patient survival rates.
Clinical trials are currently underway at major oncology centers, with the developers aiming for regulatory approval by early 2027 to make the technology available for routine hospital use.